GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanexa AB (OSTO:NANEXA) » Definitions » Ending Cash Position

Nanexa AB (OSTO:NANEXA) Ending Cash Position : kr47.84 Mil (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Nanexa AB Ending Cash Position?

Nanexa AB's Ending Cash Position for the quarter that ended in Mar. 2024 was kr47.84 Mil.

Nanexa AB's quarterly Ending Cash Position increased from Sep. 2023 (kr20.57 Mil) to Dec. 2023 (kr65.17 Mil) but then declined from Dec. 2023 (kr65.17 Mil) to Mar. 2024 (kr47.84 Mil).

Nanexa AB's annual Ending Cash Position declined from Dec. 2021 (kr105.66 Mil) to Dec. 2022 (kr81.18 Mil) and declined from Dec. 2022 (kr81.18 Mil) to Dec. 2023 (kr65.17 Mil).


Nanexa AB Ending Cash Position Historical Data

The historical data trend for Nanexa AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanexa AB Ending Cash Position Chart

Nanexa AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 11.38 12.69 105.66 81.18 65.17

Nanexa AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.50 38.36 20.57 65.17 47.84

Nanexa AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Nanexa AB's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=81.182+-16.014
=65.17

Nanexa AB's Ending Cash Position for the quarter that ended in Mar. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=65.168+-17.329
=47.84


Nanexa AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Nanexa AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanexa AB (OSTO:NANEXA) Business Description

Traded in Other Exchanges
N/A
Address
Virdings Alle 32B, Uppsala, SWE, 75450
Nanexa AB is a pharmaceutical company developing injectable drug products based on the proprietary and innovative drug delivery system PharmaShell - the high drug load delivery system enabling the next generation long-acting injectables through atomic layer precision. The company develops its own products and also has collaboration agreements with several pharma companies, among others AstraZeneca.

Nanexa AB (OSTO:NANEXA) Headlines

No Headlines